This message contains images. If you don't see images, click here to view.
Advertise in this news brief.
|
|
|
Not an AzPA member?
Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings.
|
|
|
|
Get your holiday shopping done early with Arizona Pharmacy Foundation
AzPA
It's easy to support pharmacy education this holiday season. Before grocery shopping, connect your Fry's VIP card to APF through the Fry's Community Rewards Program. Shop online with AmazonSmile. Or give a gift card that you purchase from APF. Click here to learn more.
PRODUCT SHOWCASE
Save $50 if you register before Jan. 16: Anticoagulation Certificate Program
AzPA
Join AzPA at JW Marriott in Tucson Feb. 20 for a comprehensive Anticoagulation Certificate program designed to provide pharmacists with the basic knowledge to care for patients taking anticoagulation therapies. By completing this course, pharmacists can earn 22 hours of continuing education credit while becoming certified in anticoagulation management. Register today!
Save $35 register today: Southwestern Clinical Pharmacy Seminar
AzPA
Join AzPA at JW Marriott in Tucson this Feb. 21-22 for our Southwestern Clinical. This is your chance to earn up to 12 CPEs. Attend sessions on drug updates, medication adherence, pharmacy law and more. Full schedule coming soon. Save $35 with early bird pricing ending Jan. 16.
Webinar available: DEA Final Rule for disposal of controlled substances
AzPA
The Arizona Pharmacy Association has partnered with the Pharmacy Society of Wisconsin to make available an online, continuing education course on the DEA Final Rule for the Disposal of Controlled Substances. The release of the DEA Final Rule regarding disposal of controlled substances provides for expanded methods of controlled substance disposal for community members, patients and long-term care facility residents. The rule has significant implications for pharmacies, hospitals/clinics, long-term care facilities, hospice, law enforcement and others. This webinar provides an overview of the DEA Final Rule.
The registration fee for this course is $95. CE for this webinar is available for pharmacists and pharmacy technicians.
Those that register for this webinar have access to the following resources.
- Recorded webinar
- Written analysis of the Final Rule
- Webinar slides
- Links to additional resources from DEA
To register for this course, click here. You will need to select the "log-in" option to create a user account in order to process your registration. Questions can be directed to info@pswi.org.
|
Miss an issue of the AzPA Pharmacy Flash? Click here to visit the AzPA Pharmacy Flash archive page.
|
| Date |
Event |
More Information |
| Dec. 7-12 |
ASHP Midyear Clinical Meeting and Exhibition |
Details |
| Feb. 20 |
Anticoagulation Certificate Program 2015 |
Details |
| Feb. 21-22 |
Southwestern Clinical Pharmacy Seminar |
Details |
Why are pharmacists not reporting adverse drug events?
By Jennifer S. O'Reilly
 Reporting an adverse drug reaction helps the pharmacist, the drug company that manufactures the drug, and the patient. When pharmacists do not report these events, it can hamper issues of medication errors and do the patient more harm than good. But why do pharmacists let adverse drug events go unreported? According to a recent study, there are many factors involved, and some may surprise you.
Text messages remind people to take medications
HealthDay News
Text reminders improve the chances that patients will stick with their medication regimen, a new study finds. About one-third of people don't take their medications as prescribed, either because they forget or because they're uncertain about the benefits or potential harms of the drugs, according to the researchers.
FDA issues final rule on changes to pregnancy and lactation labeling information for prescription drug and biological products
Medical News Today
The U.S. Food and Drug Administration has published a final rule that sets standards for how information about using medicines during pregnancy and breastfeeding is presented in the labeling of prescription drugs and biological products. The new content and formatting requirements will provide a more consistent way to include relevant information about the risks and benefits of prescription drugs and biological products used during pregnancy and breastfeeding.
Missed last week's issue? See which articles your colleagues read most.
$135 million deal proposed in New England Compounding Pharmacy bankruptcy case
The Boston Globe
The fund to compensate victims of a deadly 2012 meningitis outbreak linked to tainted drugs at a defunct Framingham pharmacy could increase by more than $35 million, lawyers involved in bankruptcy negotiations said.
UNC pharmacy school gets $100 million gift
WUNC-FM
 A UNC Chapel Hill alum has committed the largest individual gift ever to the university. The $100 million dollars is for the pharmacy school. UNC Chapel Hill Chancellor Carol Folt made the announcement outside the Eshelman School of Pharmacy.
Scientists may have spotted genetic cause of 'gigantism'
HealthDay News
Researchers say they've honed in on the possible genetic cause of a rare condition called gigantism that causes excessive growth in children. "Gigantism is a disease in childhood that characterized by excessive growth, resulting from an excess of growth hormone production" by the pituitary gland, explained Dr. Patricia Vuguin, a pediatric endocrinologist at Cohen Children's Medical Center in New Hyde Park, New York.
Most Americans agree with right-to-die movement
Philly.com
Already-strong public support for right-to-die legislation has grown even stronger in the days since the planned death of 29-year-old brain cancer patient Brittany Maynard, a new HealthDay/Harris Poll has found. An overwhelming 74 percent of American adults now believe that terminally ill patients who are in great pain should have the right to end their lives, the poll found. Only 14 percent were opposed.
Researchers examining new paths to treat pain and inflammation
By Dorothy L. Tengler
Pain of any type — whether acute or chronic — is the most frequent reason for physician consultation in the United States, prompting half of all Americans to seek medical care annually. Although separate conditions, pain and inflammation are nearly always associated with each other. Despite the prevalence of these conditions, the primary options available for their treatment have changed surprisingly little in recent years. Steroids, nonsteroidal anti-inflammatory drugs and opiates are still the mainstay treatments, although all have their drawbacks.
Tennessee pharmacy guilty of selling contaminated drugs
The Tennessean
A Tennessee pharmacy and its owner have pleaded guilty to violating federal law by making and distributing contaminated drugs. The product, methylprednisolone acetate, was the same steroid made by a Massachusetts compounding pharmacy that caused the 2012 outbreak of fungal meningitis, sickening 751 people across the nation with 64 deaths.
| Looking for similar articles? Search here, keyword CONTAMINATED DRUGS. |
|
Statins associated with increased survival in patients with colorectal cancer
Pharmacy Practice News
Statin use in patients with colorectal cancer was associated with a significant reduction in cancer-related mortality and longer rates of survival in a recent study.
|
|
|
|
|
AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit
Danielle Wegert, Assistant Executive Editor, 469.420.2696
Contribute news
Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.
This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
|
|
Recent issues
Dec. 3, 2014
Nov. 26, 2014
Nov. 19, 2014
Nov. 12, 2014
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
Mobile version
